Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
The Efficacy and Safety of Degludec Use for Glycemic Control in Critically Ill Patients: A Prospective Interventional Study King Faisal Specialist Hospital and Research Center Ongoing INSULIN ASPART,INSULIN DEGLUDEC 3 1 King Faisal Specialist Hospital and Research Center (Riyadh)
Assessment of Quality of Life in Patients with Relapsing Multiple Sclerosis treated with Cladribine tablets in the Kingdom of Saudi Arabia King Fahad Medical City Ongoing Cladribine 4 MS700568-2 King Fahad Medical City (Riyadh)
Medical treatment for congenital hereditary endothelial dystrophy King Khaled Eye Specialist Hospital Ongoing Nepafenac 2 22071-CT King Khaled Eye Specialist Hospital (Riyadh)
Randomized, Open-Label, Clinical Trial for Evaluating the Prophylactic Use of Paracetamol for Fasting-induced Headache During the First Week of Ramadan King Saud University Ongoing Paracetamol 3 E-22-7145 King Khalid University Hospital (Riyadh)
Efficacy and safety of cinacalcet in children with secondary hyperparathyroidism due to Vitamin D resistant ricket, two arms, randomized clinical trial (Phase III). King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia Ongoing MIMPARA 30MG F.C. TABLETS 3 2.1 King Faisal Specialist Hospital and Research Center (Riyadh)
"Comparison of IV ketamine with Standard Analgesia for treatment of vaso occlusive crisis in sickle cell disease." King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia Ongoing ESKETAMINE HCL 3 2211021 King Faisal Specialist Hospital and Research Center (Riyadh)
"A randomized double-blind placebo-controlled parallel group study assessing the efficacy and safety of dupilumab in patients with Allergic Fungal Rhinosinusitis (AFRS)" Sanofi Ongoing Dupilumab 3 EFC16724 King Khalid University Hospital (Riyadh)
A Phase 2 study of PHE885, B-cell maturation Antigen (BCMA)-directed CAR-T Cells in adult participants with relapsed and refractory multiple myeloma. Novartis Ongoing PHE885 (CAR-T Cell) 2 CPHE885B12201 King Faisal Specialist Hospital and Research Center (Riyadh)
Stress Hydrocortisone in Pediatric Septic Shock (The SHIPSS trial) King Abdullah International Medical Research Center (KAIMRC) Ongoing Hydrocortisone 4 SCT22R/009 King Abdulaziz Medical City NG (Riyadh)
iOUTRUN: Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients AstraZeneca Ongoing Benralizumab 4 D3250R0011 King Fahad Medical City (Riyadh)
View 1 - 10 From 674